In contrast, in cancer cell lines, inhibitors of histone deacetylases indirectly favor acetylation of Lys 91, 103, 116, and 430 at the nuclear level (Zhang et al., 2018) and increase TFEB transcriptional activity. The gene discussed is TFEB; the disease is cancer.